Antipruritic action of thalidomide

Acta Dermato-Venereologica

Volumn 80, Issue 1, 2000, Pages 24-25

  Martina Daly, B ^a   Shuster, Sam ^b  

^a BURNLEY GENERAL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Antipruritic drugs; Pruritus; Thalidomide

Indexed keywords

THALIDOMIDE;

ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ECZEMA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PRURIGO; PRURITUS; PSORIASIS; SCRATCHING; UNIVERSITY HOSPITAL;

EID: 0033952219     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155500750012450     Document Type: Article

References (9)

1. 1. Powell RJ. New roles for thalidomide. Br Med J 1996; 313: 377.
2. 2. Van den Broek H. Treatment of prurigo nodularis with thalidomide. Arch Dermatol 1980; 116: 571-572.
3. 3. Barnhill RL, McDougall AC. Thalidomide; use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol 1982; 7: 317-323.
4. 4. Shuster S. Dermatology in internal medicine. Oxford: Oxford University Press, 1979: 39.
5. 5. Felix RH, Shusler S. A new method for the measurement of itch and the response to treatment. Br J Dermatol 1975; 93: 303-312.
6. 6. Muston H, Felix R, Shuster S. Differential effect of hypnotics and anxiolytics on itch and scratch. J Invest Dermatol 1979; 72: 283.
7. 7. Shuster S. Reason and the rash. Proc Roy Inst GB 1981; 53: 136 163.
8. 8. Krause LB, Shuster S. The mechanism of action of antipruritic drugs. Br Med J 1983; 187: 1199-1200.
9. 9. Silva RBS, Viana PCF, Lugon NV, Hoelte M, Ruzany F, Lugon JR. Thalidomide for the treatment of uraemic pruritus: a crossover randomised double-blind trial. Nephron 1994; 67: 270-273.